Brain-Computer Interface Becomes Reality: Five Concept Stocks Receive Over 100 Institutional Visits This Year

People's Finance News, March 24th: According to the National Healthcare Security Administration (NHSA), on March 13th, the world’s first invasive brain-computer interface medical device was officially approved for marketing. On March 15th, the NHSA took the initiative to connect and provide upfront services, completing the medical insurance coding for the product. This achievement successfully facilitated a key step for the innovative product from approval to clinical application, marking that the brain-computer interface industry has officially shifted from a "planning blueprint" into the "fast lane of implementation."

According to statistics from the Securities Times·Data Treasure, since the beginning of this year, 12 brain-computer interface concept stocks have been surveyed by institutions. Among them, five stocks have been surveyed by more than 110 institutions, respectively.Sunnyou、Jiangsu Apon Medical Technology Co., Ltd.、Entropik Technology、Biotest BiotechAndSanqi Interactive Entertainment(Maintain Rights)。

As of the closing on March 23, the total A-share market value of brain-computer interface concept stocks was 475.497 billion yuan. Since the beginning of this year, brain-computer interface concept stocks have generally retreated. Compared with the closing price on March 23 and the annual high, the average retreat reached 30.96%.Haige Communications、PuliteSunnyou, Biotest Biotech retreats significantly.